Paradoxical inflammation induced by anti-TNF agents in patients with IBD. [electronic resource]
Producer: 20130205Description: 496-503 p. digitalISSN:- 1759-5053
- Adalimumab
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Arthritis -- chemically induced
- Disease Management
- Drug Eruptions -- epidemiology
- Humans
- Inflammatory Bowel Diseases -- drug therapy
- Infliximab
- Prevalence
- Sarcoidosis -- chemically induced
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.